Re-induction or Redirection? Lessons From the REScUE Trial on Ustekinumab Intensification in Crohn's Disease. Burisch J. Gastroenterology 2026 Mar 27:S0016-5085(26)00305.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Burisch J. Re-induction or Redirection? Lessons From the REScUE Trial on Ustekinumab Intensification in Crohn's Disease. Gastroenterology 2026 Mar 27:S0016-5085(26)00305.
PMID: 41905431